TORONTO -- (MARKET WIRE) -- October 17, 2006 -- Generex Biotechnology Corporation (NASDAQ: GNBT), the leader in drug delivery for metabolic diseases through the inner lining of the mouth, announced today that it has filed its Form 10-K Annual Report for the fiscal year of the Company ended July 31, 2006 with the United States Securities and Exchange Commission.
